Showing results (1441-1450 of 1,861) with videos related to

Sort By:
Pageof 187
Annals of Neurology|November 30, 2005
Recovery and brain reorganization after stroke in adult and aged ratsTiffanie M Markus, Shih-Yen Tsai, Melanie R Bollnow, et al.
Cell Systems|February 5, 2018
Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant PedigreesStephanie A Zlatic, Alysia Vrailas-Mortimer, Avanti Gokhale, et al.
Molecular Biology and Evolution|January 15, 2017
Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to AmplificationWilliam K K Wu, Xiangchun Li, Xiansong Wang, et al.
Nature Communications|June 18, 2026
L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasisJin Suk Park, Yasemin Kaygusuz, Carson Kenum, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2019
Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteriaBrian M Luna, Ksenia Ershova, Jun Yan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen PresentationCharles M Rudin, David Balli, W Victoria Lai, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
HIV Medicine|August 14, 2015
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational periodK Aebi-Popp, R Kouyos, B Bertisch, et al.
Cancer Chemotherapy and Pharmacology|February 19, 2010
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignanciesPaul K Paik, Charles M Rudin, Andrew Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2016
In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor KillingSteffi Lehmann, Ramanil Perera, Hans-Peter Grimm, et al.
Pageof 187